This site is archived and is no longer updated. It will be taken offline in mid-July. All the latest AWMSG recommendations, guidance and information is available on our new website at: https://awmsg.nhs.wales/.
awmsg logo



zolpidem tartrate (Edluar®)


Reference No. 1942

Publication date:
23/01/2013


Appraisal information

zolpidem tartrate (Edluar®) 5 mg sublingual tablet


Company: Meda Pharmaceuticals Ltd
BNF category: Central nervous system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 16/01/2013

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, zolpidem tartrate (Edluar®) cannot be endorsed for use within NHS Wales for the short term treatment of insomnia.
Statement of Advice (SOA)
Download